Teton Advisors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
FLAM
AAM
KLCMU
RSCM
Teton Advisors's XENT Position: Q4 2021 in Review
Teton Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 18,000 shares — an estimated $490K sold.
Teton Advisors first reported a position in XENT in Q2 2020 and held it in 6 quarters. The position peaked at $490K in Q3 2021. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.
- Teton Advisors reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
- Teton Advisors sold 18,000 Intersect ENT, Inc shares in Q4 2021, an estimated $490K.
- Teton Advisors first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 6 quarters.
- Teton Advisors's Intersect ENT, Inc position peaked at $490K in Q3 2021.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.
Based on Teton Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.